article thumbnail

Achieving commercial excellence with data-driven decisions

pharmaphorum

Apart from manual transfers of documents between colleagues, the data is relegated to one’s hard drive and can’t be queried at scale to evaluate performance or to inform future projects. Visit www.enaviahub.com or write to us at contact@purpleleafstrategy.com for a demo.

article thumbnail

A Reuters Pharma conversation with EY: smart reviewing and payment outcomes

pharmaphorum

EY was also running demos of EY’s Smart Reviewer, a transformational approach to reviewing promotional materials of life sciences companies. It also benefits pharma companies: instead of highly skilled reviewers spending time reviewing basic errors, identifying grammatical errors in documents, they no longer need to focus on that.

Dosage 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DSCSA

Ramblings of a pharmacist

As I’ve discussed before on this blog, counterfeit products DO exist and even have the apparently appropriate T3 documents to validate their legitimacy. The point of this law from my perspective is to attempt to prevent counterfeit products from entering the drug supply chain. Choose a vendor to send/receive EPCIS data on your behalf.

article thumbnail

Five Things To Know: How To Use Artificial Intelligence To Be A Better Clinical Pharmacist

ID Stewardship

Ctrl+F, but better Believe it or not, the reliable Ctrl+F command, cherished for bringing simplicity to document-searching, has been eclipsed by the advancements of AI. Ctrl+F can struggle with vague or common terms, making it challenging to find specific information in dense documents. No problem.